These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12412479)

  • 21. Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent--application to a human single-chain Fv fragment.
    Tsumoto K; Shinoki K; Kondo H; Uchikawa M; Juji T; Kumagai I
    J Immunol Methods; 1998 Oct; 219(1-2):119-29. PubMed ID: 9831393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
    Brinkmann U
    In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
    Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Improved biochemical characteristics of human disulfide-stabilized Fv fragment to rabies virus].
    Zhao XL; Yin J; Zhang SJ; Chen WQ
    Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):265-9. PubMed ID: 16013487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production and characterization of an active single-chain variable fragment antibody recognizing CD25.
    Muramatsu H; Yoshikawa K; Hayashi T; Takasu S; Kawada Y; Uchida K; Sato S; Takahashi T; Saga S; Ueda R
    Cancer Lett; 2005 Jul; 225(2):225-36. PubMed ID: 15978327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recombinant immunotoxin for cancer therapy: current status and prospective].
    Nagata S
    Tanpakushitsu Kakusan Koso; 2001 Mar; 46(4 Suppl):540-6. PubMed ID: 11268658
    [No Abstract]   [Full Text] [Related]  

  • 27. Generating improved single-chain Fv molecules for tumor targeting.
    Adams GP; Schier R
    J Immunol Methods; 1999 Dec; 231(1-2):249-60. PubMed ID: 10648942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli.
    Jurado P; Ritz D; Beckwith J; de Lorenzo V; Fernández LA
    J Mol Biol; 2002 Jun; 320(1):1-10. PubMed ID: 12079330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermal stabilization of a single-chain Fv antibody fragment by introduction of a disulphide bond.
    Young NM; MacKenzie CR; Narang SA; Oomen RP; Baenziger JE
    FEBS Lett; 1995 Dec; 377(2):135-9. PubMed ID: 8543036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stabilization of a recombinant Fv fragment by base-loop interconnection and V(H)-V(L) permutation.
    Brinkmann U; Di Carlo A; Vasmatzis G; Kurochkina N; Beers R; Lee B; Pastan I
    J Mol Biol; 1997 Apr; 268(1):107-17. PubMed ID: 9149145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotoxin: A new tool for cancer therapy.
    Allahyari H; Heidari S; Ghamgosha M; Saffarian P; Amani J
    Tumour Biol; 2017 Feb; 39(2):1010428317692226. PubMed ID: 28218037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotoxins in cancer therapy: Review and update.
    Akbari B; Farajnia S; Ahdi Khosroshahi S; Safari F; Yousefi M; Dariushnejad H; Rahbarnia L
    Int Rev Immunol; 2017 Jul; 36(4):207-219. PubMed ID: 28282218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double chip protein arrays using recombinant single-chain Fv antibody fragments.
    Gilbert I; Schiffmann S; Rubenwolf S; Jensen K; Mai T; Albrecht C; Lankenau A; Beste G; Blank K; Gaub HE; Clausen-Schaumann H
    Proteomics; 2004 May; 4(5):1417-20. PubMed ID: 15188410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant immunotoxins for treating cancer.
    FitzGerald DJ; Kreitman R; Wilson W; Squires D; Pastan I
    Int J Med Microbiol; 2004 Apr; 293(7-8):577-82. PubMed ID: 15149034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular single-chain Fv antibodies--a knockout punch for neoplastic cells?
    Adams GP; Weiner LM
    Gynecol Oncol; 1995 Oct; 59(1):6-7. PubMed ID: 7557617
    [No Abstract]   [Full Text] [Related]  

  • 36. Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments.
    Boel E; Verlaan S; Poppelier MJ; Westerdaal NA; Van Strijp JA; Logtenberg T
    J Immunol Methods; 2000 May; 239(1-2):153-66. PubMed ID: 10821956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
    Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
    Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A; Plückthun A
    Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding.
    Proba K; Honegger A; Plückthun A
    J Mol Biol; 1997 Jan; 265(2):161-72. PubMed ID: 9020980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies to Reduce the Immunogenicity of Recombinant Immunotoxins.
    Mazor R; King EM; Pastan I
    Am J Pathol; 2018 Aug; 188(8):1736-1743. PubMed ID: 29870741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.